The MedTech industry generated $584 billion in revenues in 2025, marking its seventh consecutive year of growth. Despite facing challenges such as geopolitical tensions, supply-chain disruptions, and reduced federal funding impacting demand, major companies are poised for further development in 2026. Notably, average transaction sizes in M&A activity rose 11% from 2024, reflecting a shift toward fewer but larger deals.
Technological advancements are central to growth, with over 250 AI-enabled medical devices authorized by the FDA in 2025, primarily in Radiology. Key players like Intuitive Surgical, Boston Scientific, Insulet, and IDEXX Laboratories are expected to lead the market, each with projected revenue growth rates of 14.3%, 11.1%, 19.8%, and 8.9% for 2026, respectively. The global medical device market is anticipated to grow at a CAGR of 5.94% from 2026 to 2035.
Among emerging technologies, regenerative medicine, digital twins, and AI-powered robotic surgery are highlighted for their potential. AI-assisted robotic surgeries, for example, demonstrated a 25% reduction in operative time and a 30% decrease in intraoperative complications compared to manual methods.
